Multiple sclerosis and epileptic seizures

Multiple Sclerosis Journal

Volumn 17, Issue 1, 2011, Pages 96-102

  Catenoix, H ^a,b,c   Marignier, R ^a,b,d   Ritleng, C ^a,d   Dufour, M ^a,d   Mauguiere F ^a,b,c   Confavreux, C ^a,b,c,d   Vukusic, S ^a,b,c,d  

^a HÔPITAL NEUROLOGIQUE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Institut Federatif des Neurosciences de Lyon   (France)

^d Service de Neurologie A   (France)

Author keywords

disability; epilepsy; multiple sclerosis; seizures; status epilepticus; treatment

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLATIRAMER; INTERFERON; METHOTREXATE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; GRAND MAL SEIZURE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; PRESCHOOL CHILD; RISK; SCHOOL CHILD; SEIZURE; TONIC CLONIC SEIZURE;

EID: 78650992627     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510382246     Document Type: Article

References (36)

1. Koch M., Uyttenboogaart M., Polman S. and De Keyser J. Seizures in multiple sclerosis. Epilepsia 2008 ; 49: 948-953.
2. Banerjee PN, Filippi D. and Allen Hauser W. The descriptive epidemiology of epilepsy - a review. Epilespy Res 2009 ; 85: 31-45.
3. Kinnunen E. and Wikström J. Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia 1986 ; 27: 729-733.
4. Waxman SG Clinico-pathological correlations in multiple sclerosis and related disorders. In: Waxman SG, Ritchie JM (eds) Advances in Neurology. Vol 31, New York: Raven Press, 1981.
5. Hirsch HE and Parks ME Na+- and K+-dependent adenosine triphosphate changes in multiple sclerosis plaque. Ann Neurol 1983 ; 13: 658-663.
6. Brownell B. and Hughes JT The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psy 1962 ; 25: 315-320.
7. Thompson AJ, Kermode AG, Moseley IF, MacManus DG and McDonald WI Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psy 1993 ; 56: 1317-1320.
8. Calabrese M., De Stefano N., Atzori M., Bernardi V., Mattisi I., Barachino L., et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 2008 ; 255: 581-586.
9. Spatt J., Chaix R. and Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol 2001 ; 248: 2-9.
10. Confavreux C., Vukusic S., Moreau T. and Adeleine P. Relapses and progression of disability in multiples sclerosis. N Engl J Med 2000 ; 16: 1486-1487.
11. Confavreux C., Compston DA, Hommers OR, Mc Donald WI and Thompson AJ EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psy 1992 ; 55: 671-676.
12. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
13. Lublin FD and Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996 ; 46: 907-911.
14. Kurtzke JF Rating neurology impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
15. Confavreux C. and Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006 ; 129: 595-605.
16. Nyquist P., Cascino G. and Rodriguez M. Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990-1998. Mayo Clin Proc 2001 ; 76: 983-986.
17. Poser CM and Brinar VV Epilepsy and multiple sclerosis. Epilepsy Behav 2003 ; 4: 6-12.
18. Nicoletti A., Sofia V., Biondi R., Lo Fermo S., Reggio E., Patti F., et al. Epilepsy and multiple sclerosis in Sicily: a population-based study. Epilepsia 2003 ; 44: 1445-1448.
19. Kelley BJ and Rodriguez M. Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs 2009 ; 23: 805-815.
20. Striano P., Orefice G., Brescia Morra V., Boccella P., Sarappa C., Lanzillo R., et al. Epileptic seizures in multiple sclerosis: clinical and EEG correlations. Neurol Sci 2003 ; 24: 322-328.
21. Munschauer FE and Kinkel RP Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis. Clint Ther 1997 ; 19: 883-893.
22. Cendrowski W. and Majowski J. Epilepsy in multiple sclerosis. Neurol Sci 1972 ; 17: 389-398.
23. Sanders JW and Shorvon SD Epidemiology of the epilepsies. J Neurol Neurosurg Psy 1996 ; 61: 433-443.
24. Moreau Th, Sochurkova D., Lemesle M., Madinier G., Billiar Th, Giroud M., et al. Epilepsy in patients with multiple sclerosis: radiological-clinical correlations. Epilepsia 1998 ; 39: 893-896.
25. Striano P., Striano S., Carrieri PB and Boccella P. Epilepsia partialis continua as a first symptom of multiple sclerosis: electrophysiological study of one case. Mult Scler 2003 ; 9: 199-203.
26. Engelsen BA and Grønning M. Epileptic seizures in patients with multiple sclerosis Is the prognosis of epilepsy underestimated? Seizure 1997 ; 6: 377-382.
27. Drake Jr WE and Macrae D. Epilepsy in multiple sclerosis. Neurology 1961 ; 11: 810-816.
28. Ghezzi A., Montanini R., Basso P., Zaffaroni M., Massimo E. and Cazzullo C. Epilepsy in multiple sclerosis. Eur Neurol 1990 ; 30: 218-223.
29. Truyen L., Barkhof F., Frequin ST, Polman CH, Tobi H., Hommes OR, et al. Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine. Mult Scler 1996 ; 1: 213-217.
30. Koch MW, Polman SK, Uytenboogaart M. and De Keyzer J. Treatment of seizures in multiple sclerosis. Cochrane Databse Syst Rev 2009 ; 8: CD007150.
31. Sokic DV, Stojsavljevic N., Drulovic J., Dujmovic I., Mesaros S., Ercegovac M., et al. Seizures in multiple sclerosis. Epilepsia 2001 ; 42: 72-79.
32. Shorvon S. Status epilepticus. Its clinical features and treatment in children and adults. Cambridge: Cambridge, University Press, 1994.
33. Renoux C., Vukusic S., Mikaellof Y., et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007 ; 356: 2603-2613.
34. Mathews WB Symptoms and signs. In: Matthews WB (ed.) McAlpine's Multiple Sclerosis, 2 nd ed. Edinburgh: Churchill Livingstone, 1991, pp. 61-63.
35. Lebrun C. Epilepsy and multiple sclerosis. Epileptic Disord 2006 ; 8: S55 - S58.
36. Grassiot B., Desgranges B., Eustache F. and Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009 ; 256: 1397-1412.